Gene · 9201
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ELF1's Role in Colorectal Cancer: Up-Regulating DCLK1 Expression to Propel Malignant Progression and Stemness Features. | Discov Med | 2025 | 39973554 | PubTator, text mining | PubMed |
| Inhibition of stemness and PD-L1 expression by Pien Tze Huang enhances T cell-mediated killing of colorectal cancer. | J Ethnopharmacol | 2025 | 39914691 | PubTator, text mining | PubMed |
| Chemical genetics reveals cross-regulation of plant developmental signaling by the immune peptide-receptor pathway. | Sci Adv | 2025 | 39908379 | PubTator, text mining | PubMed |
| Prostaglandin E2 and Akt Promote Stemness in Apc Mutant Dclk1+ Cells to Give Rise to Colitis-associated Cancer. | Cell Mol Gastroenterol Hepatol | 2025 | 39884575 | PubTator, text mining | PubMed |
| Doublecortin-like kinase 1 promotes stem cell-like properties through the Hippo-YAP pathway in prostate cancer. | Int J Med Sci | 2025 | 39781521 | PubTator, text mining | PubMed |
| Leucine drives LAT1-related SNAIL upregulation in glucose-starved pancreatic cancer cells. | Med Mol Morphol | 2025 | 39240293 | PubTator, text mining | PubMed |
| Jiedu Xiaozheng Yin extract targets cancer stem cells by Wnt signaling pathway in colorectal cancer. | J Ethnopharmacol | 2025 | 39197803 | PubTator, text mining | PubMed |
| Short histological kaleidoscope - recent findings in histology. Part IV. | Rom J Morphol Embryol | 2024 | 39529332 | PubTator, text mining | PubMed |
| Emerging insights into ferroptosis in cholangiocarcinoma (Review). | Oncol Lett | 2024 | 39483963 | PubTator, text mining | PubMed |
| DCLK1 mediated cooperative acceleration of EMT by avian leukosis virus subgroup J and Marek's disease virus via the Wnt/β-catenin pathway promotes tumor metastasis. | J Virol | 2024 | 39445786 | PubTator, text mining | PubMed |
| DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression. | Sci Signal | 2024 | 39288218 | PubTator, text mining | PubMed |
| Allosteric regulation of kinase activity. | Elife | 2024 | 38984616 | PubTator, text mining | PubMed |
| Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression. | J Cancer Res Clin Oncol | 2024 | 38980538 | PubTator, text mining | PubMed |
| A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1-JNK pathway-dependent chemokines. | FASEB J | 2024 | 38965999 | PubTator, text mining | PubMed |
| From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. | Int J Mol Sci | 2024 | 38928187 | PubTator, text mining | PubMed |
| DCLK1 Expression and its Functional Significance in Intrahepatic Cholangiocarcinoma and Bil-IN Stage. | Anticancer Res | 2024 | 38821583 | PubTator, text mining | PubMed |
| Repurposing diacerein to suppress colorectal cancer growth by inhibiting the DCLK1/STAT3 signaling pathway. | Chin J Nat Med | 2024 | 38658095 | PubTator, text mining | PubMed |
| Subtyping of triple-negative breast cancers: its prognostication and implications in diagnosis of breast origin. | ESMO Open | 2024 | 38613910 | PubTator, text mining | PubMed |
| An auxiliary strategy of partial least squares regression in pharmacokinetic/pharmacodynamic studies: A case of application of guhong injection in myocardial ischemia/reperfusion rats. | J Food Drug Anal | 2024 | 38526587 | PubTator, text mining | PubMed |
| E74-like ETS transcription factor 1 promotes the progression of pancreatic cancer by regulating doublecortin-like kinase 1/Janus kinase/signal transducer and activator of transcription pathway. | Am J Cancer Res | 2024 | 38455425 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9201/papers?page=4